Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diluted ropivacaine in uterine distending fluid for pain after hysteroscopy
IRCT20160527028109N4Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine in postoperative pain, sponsored by Iran University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20160527028109N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160527028109N4.